Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.
about
CHD6 is a DNA-dependent ATPase and localizes at nuclear sites of mRNA synthesisMolecular architecture of quartet MOZ/MORF histone acetyltransferase complexesMOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP functionMOZ and MORF, two large MYSTic HATs in normal and cancer stem cellsPPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndromeMolecular and phenotypic aspects of CHD7 mutation in CHARGE syndromeRole of Nuclear Receptors in Central Nervous System Development and Associated DiseasesMolecular implications of evolutionary differences in CHD double chromodomains.Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.Discovery of genes implicated in whirling disease infection and resistance in rainbow trout using genome-wide expression profiling.Signatures of Archaic Adaptive Introgression in Present-Day Human Populations.PPARalpha: energy combustion, hypolipidemia, inflammation and cancerMED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor gamma and is required for full transcriptional activity and adipogenesis.Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicityNormal and cancer-related functions of the p160 steroid receptor co-activator (SRC) familyCoactivators in PPAR-Regulated Gene ExpressionPRIC295, a Nuclear Receptor Coactivator, Identified from PPARα-Interacting Cofactor ComplexThe KAT6B-related disorders genitopatellar syndrome and Ohdo/SBBYS syndrome have distinct clinical features reflecting distinct molecular mechanismsHepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse.Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensingGenetic-dependency of peroxisomal cell functions - emerging aspects.Metabolic Functions of Peroxisome Proliferator-Activated Receptor beta/delta in Skeletal Muscle.The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.Lipid-lowering drugs.DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus.Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene.Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression.A rare nonsynonymous variant in the lipid metabolic gene HELZ2 related to primary biliary cirrhosis in Chinese Han.Nuclear Receptor Cofactors in PPARgamma-Mediated Adipogenesis and Adipocyte Energy Metabolism.A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replicationThe MYST family of histone acetyltransferases and their intimate links to cancer.Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.Nuclear receptor coactivator 6 mediates the synergistic activation of human cytochrome P-450 2C9 by the constitutive androstane receptor and hepatic nuclear factor-4alphaPeroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle.
P2860
Q24306251-53E921E7-069F-4466-924D-54A3FACCA6D4Q24312967-508358D6-62FD-4B86-B297-894085FBCB3FQ24557551-E58AD210-FFE3-484C-BD2F-F3DDBC31130FQ24570117-414E4A09-B8A0-4813-BACB-F111F2F15D05Q24633440-A2FEF16E-FAD7-4AEF-B9C1-007EE1B49308Q24633725-31FC85B4-3EB4-4A0C-80B3-CBC292858E60Q24634411-A59AF473-7254-4A09-B42A-C6230EBFF778Q27025212-5D0E03FD-A251-4DE5-9200-69C181F8644EQ27644441-79AEB3A2-9F38-4C5B-8A1F-9E3216425DA0Q30009401-D8457544-A2BD-4242-9488-EC794758C48DQ33316408-46A0A996-6A76-41D8-BA59-74FBD9391597Q33590851-F2EB0C8C-52E7-4CDE-94CA-A9C3BB3A8FF8Q33805104-84F3011F-411D-43D7-B7CE-B6F2B6949680Q33826208-85BAA862-E2D9-4F90-A14D-7ADE73184DDFQ33920005-A365B043-EC81-42D3-AAA5-41D7ED39A54CQ34013708-DBB71DF3-FC50-469C-A939-5506737CE7CEQ34089711-EDCBCB5F-D630-463F-B051-EDE07E7AA2A5Q34159503-34E1E087-639D-41F7-9922-86480F75EFACQ34282844-241DF84A-15B1-4392-9058-45D89974D164Q34380511-BCF81EBC-2A9F-4051-B88E-CDD058F41DFFQ34513687-6A9AEF9D-5DDC-46EA-9A1E-17D125B8A67EQ34789643-1F9C1C59-F889-439E-B599-07D7A2CE4024Q35002929-36A043A7-CD42-4684-96E1-10BD6E3914B6Q35098336-64895D60-6050-4D86-B64B-08DE0AA2F5BDQ35574139-58A3176E-D0A5-42BD-AF44-80868959D8AFQ35613290-04DFC577-F87D-49C3-94A3-6E6B37846712Q35666251-1E0D1779-7838-4F94-B3F9-06F4F011D4C7Q35677716-B32614E9-FE12-4288-BDD1-F74DD191882DQ36002780-13B87400-6958-4B9B-A325-7F900E6AFC20Q36081115-CF87E375-6847-45C0-A59D-2467D0311724Q36219749-AEFF784B-5FE7-4B12-BEAE-A378F6DBD487Q36415919-9FA77D87-1F24-4E50-A31D-04A75B833B2EQ36421347-9D88077E-C5F0-49AB-917D-BCD6985A5D41Q36760870-B59B8826-22F2-477D-99A5-897691060A90Q36772290-468ED3E1-3568-4A92-8D77-AF0B50BAD68FQ36881106-6FFFB98D-5418-4D46-93F2-AC06E8C8DDEEQ36908407-F64811DB-D2DF-4166-94C4-D9A7B5E5EA5AQ37238860-E55DBAD9-0295-4CE4-BC00-B754B3CCF421Q37274199-B38C9C55-2B93-40CD-8F1A-A8EF78E44DB7Q37278866-5C883A1D-158E-4D37-A90F-05F7E542E025
P2860
Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of a transcript ...... on of PRIC285 as a coactivator
@nl
Identification of a transcript ...... n of PRIC285 as a coactivator.
@ast
Identification of a transcript ...... n of PRIC285 as a coactivator.
@en
Identification of a transcript ...... n of PRIC285 as a coactivator.
@en-gb
type
label
Identification of a transcript ...... on of PRIC285 as a coactivator
@nl
Identification of a transcript ...... n of PRIC285 as a coactivator.
@ast
Identification of a transcript ...... n of PRIC285 as a coactivator.
@en
Identification of a transcript ...... n of PRIC285 as a coactivator.
@en-gb
prefLabel
Identification of a transcript ...... on of PRIC285 as a coactivator
@nl
Identification of a transcript ...... n of PRIC285 as a coactivator.
@ast
Identification of a transcript ...... n of PRIC285 as a coactivator.
@en
Identification of a transcript ...... n of PRIC285 as a coactivator.
@en-gb
P2093
P2860
P3181
P356
P1476
Identification of a transcript ...... n of PRIC285 as a coactivator.
@en
P2093
Anjana V Yeldandi
Janardan K Reddy
M Sambasiva Rao
Mustapha Cherkaoui-Malki
Papreddy Kashireddy
Sailesh Surapureddi
Songtao Yu
Takashi Hashimoto
P2860
P304
11836-11841
P3181
P356
10.1073/PNAS.182426699
P407
P577
2002-08-20T00:00:00Z